The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of pembrolizumab (P) with gemcitabine (G) in patients (Pts) with previously-treated advanced non-small cell lung cancer (NSCLC): Phase I safety results.
 
Rachel E. Sanborn
Honoraria - AstraZeneca
Consulting or Advisory Role - Amgen; ARIAD; Genentech/Roche; Peregrine Pharmaceuticals; Seagen
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
Regan M. Duffy
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
Brenda K Fisher
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - IRX Therapeutics
 
Kelly Shea Perlewitz
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
 
William L Redmond
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Galectin Therapeutics; IRX Therapeutics; MedImmune (Inst); Merck; Nektar; Tesaro
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Tesaro
 
Yoshinobu Koguchi
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Agonox
 
Bernard A. Fox
Employment - UbiVac; UbiVac (I)
Leadership - UbiVac
Stock and Other Ownership Interests - UbiVac
Honoraria - Janssen Biotech; Nodality
Consulting or Advisory Role - Dendreon; Janssen Biotech
Research Funding - Aduro Biotech; Bristol-Myers Squibb; DEfiniens; Janssen Biotech; MedImmune (Inst); Perkin Elmer; Ventana Medical Systems; Viralytics
Patents, Royalties, Other Intellectual Property - Patent around the DPV-001 cancer vaccine. This patent is owned by the Providence Health System and licensed to UbiVac